Over the past 15 years, Ehrlich has made over 200 appearances on national and regional TV and radio discussing new methods for the early detection of disease and emerging concepts in prevention and personalized medicine. Currently, Dr. Ehrlich is the National Cardiology Director for CardioDx, a Redwood City cardiovascular molecular diagnostics company. He is board certified in two fields, anesthesiology and obesity medicine. Ehlrich established Early Detection Technologies, LLC which advises on best practices involving novel biomarker, diagnostic testing and cardiovascular risk assessment, imaging technologies and radiation protection.